Remarkable results in the treatment of patients with relapsed Large B-Cell Lymphoma

Directly from ASH21 we offer you an update from the ZUMA‑7 study, A Phase 3 Randomized Trial of Axi-Cel Treatment for patients with relapsed large B-Cell Lymphoma. The results are remarkable, Axi-Cel Treatment is one of the new treatments for lymphoma patients that will likely become a new paradigm in the future. In this MEDtalk, Frederik L. Locke sums up the background of the study and presents the convincing results.